Curriculum Vitaes
Profile Information
- Affiliation
- School of Medicine Faculty of Medicine, Fujita Health University
- Degree
- 医学博士(神戸大学)
- J-GLOBAL ID
- 201901014581955606
- researchmap Member ID
- 7000029496
Research Interests
3Research Areas
1Research History
4-
Apr, 2023 - Present
-
Apr, 2019 - Mar, 2023
-
Apr, 2015 - Mar, 2019
-
Jul, 2011 - Jul, 2013
Education
2-
Apr, 2004 - Mar, 2009
-
Apr, 1995 - Mar, 2001
Committee Memberships
2-
Sep, 2021 - Present
-
Aug, 2021 - May, 2023
Major Papers
37-
Diabetology International, 8(2) 199-204, Jun 1, 2017 Peer-reviewedInsulin autoimmune syndrome (IAS) involves not only fasting hypoglycemia, but also postprandial hyperglycemia. In the present study, we hypothesized that glycated albumin (GA) levels and the GA/HbA1c ratio, which reflect fluctuations in plasma glucose levels, are elevated in IAS patients. Four IAS patients were enrolled in the present study. Thirty-two non-diabetic subjects matched for gender, age, and BMI were used as the control group. The fasting plasma glucose levels in the IAS patients were significantly lower than in the control group. However, the oral glucose tolerance test (OGTT) revealed impaired glucose tolerance or diabetes mellitus in all the IAS patients, and thus the OGTT 2-h plasma glucose levels were significantly higher than in the control group. The GA levels and the GA/HbA1c ratio in the IAS patients were significantly higher than in the control group, despite no significant difference in the HbA1c levels between the two groups. In one case in which IAS spontaneously went into remission, there was a significant correlation between anti-insulin antibodies and GA, but not HbA1c. Improvement in glucose fluctuations was observed by continuous glucose monitoring in another patient along with improvement in the clinical symptoms. Furthermore, anti-insulin antibodies, GA, and the GA/HbA1c ratio decreased, but HbA1c did not change significantly in three IAS patients along with the improvement in clinical symptoms. These results suggest that GA and the GA/HbA1c ratio are useful indicators for determining the level of disease activity in IAS patients.
Misc.
133-
診断と治療, 107(3) 324-327, Mar, 2019<Headline>1 混合型・配合溶解インスリンのメリット・デメリットを活かした使用をする。2 インスリンリスプロ50/50製剤は外来でのインスリン導入に適している。3 配合溶解インスリンのライゾデグの特徴を押さえる。(著者抄録)
-
糖尿病の最新治療, 10(2) 78-85, Feb, 2019選択的SGLT(sodium-glucose co-transporter)2阻害薬については、これまでさまざまな臨床および基礎研究が行われてきた。本稿では、SGLT2阻害薬の心血管イベントリスクに対する効果について、いくつかの試験結果をもとに解説する。具体的には、エンパグリフロジン、カナグリフロジン、ダパグリフロジン、イプラグリフロジンの心血管イベントリスク低減効果について紹介していく。EMPA-REG OUTCOME試験、CANVAS Program、DECLARE-TIMI58、CVD-REAL 2試験を取り上げるが、いずれの試験でもSGLT2阻害薬の心血管イベントリスク低減効果が認められ、大変興味深い結果になっている。SGLT2阻害薬にはほかにもさまざまな臓器保護効果が認められており、臨床において適切に選択されることが期待される。(著者抄録)
Major Presentations
5Research Projects
1-
医学研究助成金, 一般財団法人 中京長寿医療研究推進財団, Apr, 2023 - Mar, 2024